I. Uno

发表

The in vitro and in vivo pharmacological profiles of a platelet glycoprotein IIb/IIIa antagonist, NSL-9403.

J. Katada, M. Muramatsu, Y. Takiguchi, 1997, Thrombosis research.

Development of the new potent non-peptide gpIIb/IIIa antagonist NSL-95301 by utilizing combinatorial technique

T. Harada, Y. Hayashi, J. Katada, 1997 .

Antitumor activity of phenylahistin in vitro and in vivo.

Y. Hayashi, K. Kanoh, J. Katada, 1999, Bioscience, biotechnology, and biochemistry.

(-)-Phenylahistin arrests cells in mitosis by inhibiting tubulin polymerization.

K. Kanoh, J. Katada, J. Takahashi, 1999, The Journal of antibiotics.

(−)-Phenylahistin: A new mammalian cell cycle inhibitor produced by aspergillus ustus

T. Harada, K. Kanoh, H. Kawashima, 1997 .

GPIIb/IIIa integrin antagonists with the new conformational restriction unit, trisubstituted beta-amino acid derivatives, and a substituted benzamidine structure.

T. Harada, J. Katada, I. Ojima, 1998, Journal of medicinal chemistry.

Development of new non-peptide GPIIb/IIIa antagonists, NSL-95315 and NSL-95317, isosteres of NSL-95300

T. Harada, Y. Hayashi, J. Katada, 1997 .

A Novel Peptide Motif for Platelet Fibrinogen Receptor Recognition*

T. Harada, Y. Hayashi, M. Muramatsu, 1996, Journal of Biological Chemistry.

Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.

T. Harada, K. Igarashi, J. Katada, 1998, Bioorganic & medicinal chemistry.

Design and synthesis of new antagonist peptides for platelet GPIIb/IIIa receptor as anti-thrombotic agents

Y. Hayashi, J. Katada, I. Ojima, 1996 .

In vitro and in vivo properties of NSL-9511, a novel anti-platelet hexapeptide without an RGD sequence

T. Harada, Y. Hayashi, J. Katada, 2002 .

Synthesis and biological activities of phenylahistin derivatives.

K. Kanoh, J. Katada, J. Takahashi, 1999, Bioorganic & medicinal chemistry.

Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2.

K. Igarashi, T. Kato, K. Igarashi, 1998, Biochemical and biophysical research communications.

Development of potent non-peptide GPIIb/IIIa antagonists with tri-substituted β-amino acid derivatives as a new conformational restriction unit

T. Harada, Y. Hayashi, J. Katada, 1999 .